Blood transfusion in hemolytic anemias

Immunohematology

Volumn 15, Issue 1, 1999, Pages 15-23

  Petz, L D ^a,b  

^a Depts of Pathology and Medicine   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; AUTOANTIBODY;

ADSORPTION; BLOOD DONOR; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BONE MARROW TRANSPLANTATION; CLINICAL EXAMINATION; CONFERENCE PAPER; ERYTHROCYTE; ERYTHROPOIESIS; HEART FAILURE; HEMOGLOBINURIA; HEMOLYTIC ANEMIA; HUMAN; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PHENOTYPE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; TECHNIQUE; THALASSEMIA;

EID: 0033056595     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. Crosby WH, Rappaport H. Reticulocytopenia in autoimmune hemolytic anemia. Blood 1956; 11:929-36.
2. Conley CL, Lippman SM, Ness PM, Petz LD, Branch DR, Gallagher MT. Autoimmune hemolytic anemia with reticulocytopenia and erythroid marrow. N Engl J Med 1982; 306:281-6.
3. Garratty G, Petz LD. Transfusing patients with autoimmune haemolytic anaemia. Lancet 1993; 341:1220.
4. Petz LD, Garratty G. Acquired immune hemolytic anemias. New York; Churchill Livingstone, 1980.
5. Branch DR, Petz LD. A new reagent ZZAP having multiple applications in immunohematology. Am J of Clin Pathol 1982;78:161-7.
6. Vengelen-Tyler V, ed. Technical manual. 12th ed. Bethesda,MD: American Association of Blood Banks, 1996.
7. Petz LD. Autoimmune hemolytic anemia. Hum Pathol 1983; 14:251-5.
8. Petz LD. Blood transfusion in acquired hemolytic anemia. In: Petz LD, Swisher SN, Kleinman S, Spence RK, Strauss RG, eds. Clinical practice of transfusion medicine. 3rd ed. New York: Churchill Livingstone, 1996:469-99.
9. Menitove JE, ed. Standards for blood banks and transfusion services. 18th ed. Bethesda, MD: American Association of Blood Banks, 1997.
10. Jefferies LC. Transfusion therapy in autoimmune hemolytic anemia. Hematology/Oncology Clinics of North America 1994;8:1087-1104.
11. Morel PA, Bergen MO, Frank BA. A simple method for the detection of alloantibody in the presence of warm autoantibody (abstract). Transfusion 1978; 18:388.
12. Wallhermfechtel MA, Pohl BA, Chaplin H. Alloimmunization in patients with warm autoantibodies. A retrospective study employing three donor alloabsorptions to aid in antibody detection. Transfusion 1984;24:482-5.
13. Laine ML, Beattie KM. Frequency of alloantibodies accompanying autoantibodies. Transfusion 1985; 25:545-6.
14. James P, Rowe GP,Tozzo GG. Elucidation of alloantibodies in autoimmune haemolytic anaemia. Vox Sang 1988;54:167-71.
15. Sokol RJ, Hewitt S, Booker DJ, Morris BM. Patients with red cell autoantibodies: selection of blood for transfusion. Clin Lab Haematol 1988;10:257-64.
16. Issitt PD, Combs MR, Bumgarner DJ,Allen J, Kirkland A, Melroy-Carawan H. Studies of antibodies in the sera of patients who have made red cell autoantibodies. Transfusion 1996;36:481-6.
17. Leger RM, Garratty G. Evaluation of methods for detecting alloantibodies underlying warm autoantibodies. Transfusion 1999; 39:11-6.
18. Rosenfield RE, Jagathambal. Transfusion therapy for autoimmune hemolytic anemia. Seminars Hematol 1976; 13:311-21.
19. Chaplin H. Special problems in transfusion management of patients with autoimmune hemolytic anemia. In: Bell CA, ed. A seminar on laboratory management of hemolysis. Washington, D.C.: American Association of Blood Banks, 1979:135-60.
20. Bilgrami S, Cable R, Pisciotto P, Rowland F, Greenberg B. Fatal disseminated intravascular coagulation and pulmonary thrombosis following blood transfusion in a patient with severe autoimmune hemolytic anemia and human immunodeficiency virus infection. Transfusion 1994;34:248-52.
21. Salama A, Bergheofer H, Mueller-Eckhardt C. Red blood cell transfusion in warm-type autoimmune haemolytic anaemia. Lancet 1992;340:1515-7.
22. Petz LD, Calhoun L, Shulman IA, Johnson C, Herron RM. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997;37:382-92.
23. Garratty G. Severe reactions associated with transfusion of patients with sickle cell disease (editorial). Transfusion 1997;37:357-61.
24. Sirchia G, Morelati F, Rebulla P. The sickle cell hemolytic transfusion reaction syndrome (letter). Transfusion 1997; 37:1098-9.
25. Petz LD. The expanding boundaries of transfusion medicine. In: Nance SJ, ed. Clinical and basic science aspects of immunohematology. Arlington, VA: American Association of Blood Banks, 1991:73-113.
26. Chaplin HJ, Zarkowsky HS. Combined sickle cell disease and autoimmune hemolytic anemia. Arch Intern Med 1981; 141:1091-3.
27. Sosler SD, Perkins JT, Saporito C, et al. Severe autoimmune hemolytic anemia induced by transfusion in two alloimmunized patients with sickle cell disease (abstract). Transfusion 1989;29:49S.
28. Thompson RA, Rowe DS. Reactive haemolysis - a distinctive form of red cell lysis. Immunology 1968;14:745-62.
29. Thompson RA, Lachmann PJ. Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7. J Exp Med 1970;131:629-41.
30. Lachmann PJ,Thompson RA. Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C5b and the participation of C8 and C9. J Exp Med 1970; 131:643-57.
31. Yachnin S, Ruthenberg JM. The initiation and enhancement of human red cell lysis by activators of the first component of complement and by first component esterase: studies using normal red cells and red cells from patients with paroxysmal nocturnal hemoglobinuria. J Clin Invest 1965;44:518-34.
32. Sirchia G, Ferrone S, Mercuriali F. Leukocyte antigen-antibody reaction and lysis of paroxysmal nocturnal hemoglobinuria erythrocytes. Blood 1970;36:334-6.
33. Salama A, Mueller-Eckhardt C. Delayed hemolytic transfusion reactions. Evidence for complement activation involving allogeneic and autologous red cells. Transfusion 1984;24:188-93.
34. Ness PM, Shirey RS, Thoman SK, Buck SA. The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance. Transfusion 1990;30:688-93.
35. Test ST, Woolworth VS. Defective regulation of complement by the sickle erythrocyte: evidence for a defect in control of membrane attack complex formation. Blood 1994;83:842-52.
36. Gajewski JL, Petz LD, Calhoun L, et al. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate. Blood 1992;79: 3076-85.
37. Hows J, Beddow K, Gordon-Smith E, Branch DR, Spruce W, Sniecinski I, et al. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood 1986;67:177-81.
38. Greeno E, Ilstrup S, Perry E, Weidorf DJ. Total erythrocyte hemolysis following ABO minor incompatible bone marrow transplantation: rapid appearance of donor-derived red cell antibodies (abstract). Blood 1992;80 (Suppl 1):484a.
39. 1 antibody following hone marrow transplantation. Blut 1986;53:401-4.
40. 1 and auto anti-NA1 after bone marrow transplantation. Folia Haematol Int Mag Klin Morphol Blutforsch 1987;114:874-80.
41. Oziel-Taieb S, Faucher-Barbey C, Chabannon C, et al. Early and fatal immune haemolysis after so-called 'minor' ABO-incompatible peripheral blood stem cell allotransplantation. Bone Marrow Transplantation 1997;19:1155-6.
42. Toren A, Dacosta Y, Manny N, et al. Passenger B-lymphocyte-induced severe hemolytic disease after allogeneic peripheral blood stem cell transplantation. Blood 1996;87:843-4.
43. Laurencet FM, Samii K, Bressoud A, et al. Massive delayed hemolysis following peripheral blood stem cell transplantation with minor ABO incompatibility. Hematol Cell Ther 1997;39:159-62.
44. Donegan CC, MacIlwaine WA, Leavell BS. Hematologic studies on patients with sickle cell anemia following multiple transfusions. Am J Med 1954;17:29.
45. King KE, Shirey RS, Lankiewicz MW,Young-Ramsaran J, Ness PM. Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells. Transfusion 1997;37:376-81.